Centessa Pharmaceuticals (UK) Limited clinical trials
Acquired by Eli Lilly and Company, Jun 24, 2026 · source ↗
The registry lists 6 studies whose lead sponsor is Centessa Pharmaceuticals (UK) Limited. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 3, 2026.
- 6studies on the registry
- 5open to participants now
- 1phase 3 study under way
- 3reach primary completion within a year
Before and after it joined Eli Lilly and Company
- First submitted before Centessa Pharmaceuticals (UK) Limited became part of Eli Lilly and Company
- 6
- First submitted after Centessa Pharmaceuticals (UK) Limited became part of Eli Lilly and Company
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Coming up
3 of Centessa Pharmaceuticals (UK) Limited’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.
Phase 3 Other phases
- NNov ’26’26
- 1DDec
- JJan ’27’27
- FFeb
- MMar
- AApr
- MMay
- 1JJun
- JJul
- AAug
- 1SSep
- OOct
- NNov
All 3
- Dec 2026A Study of ORX750 in Participants With Narcolepsy and Idiopathic HypersomniaNCT06752668
- Jun 2027A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 YearsNCT07413666
- Sep 2027A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of HypersomnolencePhase 3 · NCT07598708
Add all 3 to your calendar (.ics) → With an account.
All 6 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 23
- 24
- 225
- 226
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Centessa Pharmaceuticals (UK) Limited6 studies
Something wrong with this grouping? Tell us on the Eli Lilly and Company page.
Studies
Recruiting first, then most recently updated. Showing 6 of 6. All Eli Lilly and Company studies →
- A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of HypersomnolenceRecruitingNCT07598708Phase 2/3
Sponsor listed in the registry: Centessa Pharmaceuticals (UK) Limited · First submitted before Centessa Pharmaceuticals (UK) Limited became part of Eli Lilly and Company
- A Study of ORX750 in Participants With Narcolepsy and Idiopathic HypersomniaRecruitingNCT06752668Phase 2
Sponsor listed in the registry: Centessa Pharmaceuticals (UK) Limited · First submitted before Centessa Pharmaceuticals (UK) Limited became part of Eli Lilly and Company
- A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic HypersomniaRecruitingNCT07096674Phase 2
Sponsor listed in the registry: Centessa Pharmaceuticals (UK) Limited · First submitted before Centessa Pharmaceuticals (UK) Limited became part of Eli Lilly and Company
- A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 YearsRecruitingNCT07413666Phase 1
Sponsor listed in the registry: Centessa Pharmaceuticals (UK) Limited · First submitted before Centessa Pharmaceuticals (UK) Limited became part of Eli Lilly and Company
- A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of AgeRecruitingNCT07082829Phase 1
Sponsor listed in the registry: Centessa Pharmaceuticals (UK) Limited · First submitted before Centessa Pharmaceuticals (UK) Limited became part of Eli Lilly and Company
- A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid TumorsTerminatedNCT05821777Phase 1/2
Sponsor listed in the registry: Centessa Pharmaceuticals (UK) Limited · First submitted before Centessa Pharmaceuticals (UK) Limited became part of Eli Lilly and Company